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Objective: To investigate the mechanism of survivin, p53 and Ki-67 on Hep-2 human
laryngeal cancer endothelial cell proliferation and invasion.
Methods: Laryngeal squamous cell carcinoma and paracancerous normal tissues were
collected, total RNA was extracted from tissues, survivin, p53 and Ki-67 gene mRNA
expression levels in laryngeal cancer and the adjacent tissues were detected by Real-time
PCR. Human laryngeal cancer Hep-2 epithelial cells were selected, survivin gene was
overexpressed, and cell proliferation was detected by MTT. p53 and Ki-67 gene
expression changes in overexpressed survivin gene were detected by Western blot.
Changes in Hep-2 cell invasive ability were studied when survivin was overexpressed as
detected by Transwell invasion assay.
Results: In the adjacent tissues, survivin, p53 and Ki-67 gene relative expression levels
were 1.72 ± 0.9, 13.7 ± 5.7 and 5.7 ± 1.3, respectively; while in cancer tissues, gene
relative expression levels were 53.7 ± 8.3, 66.7 ± 5.2 and 61.0 ± 3.1, respectively, which
was signiﬁcantly increased. As detected by MTT, relative cell survival rate within 12 h of
survivin overexpression were: load control group (88.5 ± 1.6)%; overexpressed
group (90.3 ± 1.9)%. Transwell invasion assay results indicated that overexpressed
survivin could signiﬁcantly increase the relative survival rate of cells.
Conclusions: Expressions of p53, Ki67 and survivin are increased in cancer; and there is
a positive correlation between survivin, p53 and Ki67 expressions in laryngeal carcinoma.1. Introduction
Laryngeal cancer is a commonmalignancy that is secondly high
estin disease incidence only after nasopharyngeal cancer in
otolaryngology. Although the occurrence of cancer is a multifac-
torially complex process, it is generally believed that in cancer gene
activation, tumor suppressor gene inactivation and overexpression
of anti-apoptotic genes are important causes of cancer [1–3].
In recent years, survivin has been found to be an apoptosis
inhibiting gene. It is a member of the apoptosis inhibitory protein
factor family, which is tumor speciﬁc and only expressed in tumor
and embryonic tissues; because it is expressed in a variety oftumors and highly correlated with tumor diffusion transfers.
Therefore, it has become a hot topic in cancer research. Studies
have found that survivin upregulation and p53 overexpression are
closely related to nasal type NK/T-cell lymphoma. Survivin might
prompt p53 to coordinate cell cycle regulation. Ki67 is a kind
proliferation associated with nuclear antigens. In addition, it is
expressed to all G0 phase cell cycles, and closely relatedwith tumor
differentiation, invasion and metastasis [4–8]. Therefore, in this
study, we discuss survivin with p53 and Ki-67 expressions in
laryngeal carcinoma and its correlation with Hep-2 cell prolifera-
tion and invasiveness in tissue and cell levels; in order to explore
the role of survivin in tumor occurrence and development.
2. Materials and methods
2.1. Materials
2.1.1. Hep-2 cell line
Hep-2 cell line was purchased from ATCC, and stored in
liquid nitrogen out of laboratory. Cells were cultured in DMEMen access article under the CC BY-NC-ND
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(Lanzhou MinHai Bio-engineering Co., Ltd) at 37 C with a 5%
CO2 environment.
2.1.2. Drug reagents and equipment
Tissue RNA extraction kit (RNeasy Plus Mini Kit) was
purchased from QIAGEN; Reverse transcription kit
(iScriptcDNA Synthesis Kit) was purchased from Bio-Rad;
Real-time ﬂuorescence quantitative PCR kit (SsoAdvanced
SYBR Green Super mix) was purchased from Bio-Rad; Trans-
fection Reagent lipofectamine 2000 was purchased from Invi-
trogen; MTT kit was purchased from Promega; Survivin
monoclonal antibody was purchased from Abcam; p53 and Ki67
antibodies were purchased from Santa Cruz Biotechnology;
Transwell chamber was purchased from Millipore; Matrigel
matrix (5 mg/mL) was purchased from BD.
CO2 incubator was from SANYO; UV spectrophotometer
(SmartSpec 3000) was from Bio-Rad; Shimadzu (Precision
Balances) was from Sartorius; Fluorescence quantitative PCR
detection system (CFX96 Touch) was from Bio-Rad.
2.2. Methods
2.2.1. Clinical tissue samples
Surgical specimens from 64 cases of laryngeal squamous cell
carcinoma and 34 cases of the adjacent normal tissues were
collected from January 1997 to January 2009 at the Department
of Pathology, Afﬁliated Hospital of Hebei Engineering Uni-
versity. Among the 64 cases of laryngeal cancer patients, 52
were male and 12 were female; meanwhile, 45 of them were
60-years-old and 19 were >60-years-old, with the average age
of these patients being 57.6. Clinical staging was based on the
Union for International Cancer Control 1997 standards;
accordingly, 9 cases were stage-I, 20 cases were stage-II, 28
cases were stage-III, and 7 cases were stage-IV. Among these
cases, 31 cases had cervical lymph node metastasis, while 33
cases were without cervical lymph node metastasis. After the
follow-up for 3–10 years, there were 14 deaths and 50 survival
patients in 3 years, and two lost cases and 46 survival patients in
5 years.
Mortar was added liquid nitrogen and tissues were grinded to
powder. Tissue RNA extraction kit was used to obtain total
RNA and preserved in a freezer at −80 C.
2.2.2. Real-time PCR assay method
Clinical cancer and the adjacent normal tissue samples were
collected, and separately randomized three cases into a singleTable 1
Primers used in real-time PCR.
Gene Accession no.
BIRC5 NM_001012271.1
TP53 NM_001003210.1
MKI67 NM_001145966.1
GAPDH NM_002046
BIRC5, baculoviral IAP repeat-containing 5; TP53, tumor protein p53; MK
eraldehyde 3-phosphate dehydrogenase; For, forward; Rev, reverse.sample. Survivin, p53 and Ki67 gene mRNA expression levels
were detected in tissue total RNA of all samples. According to
reverse transcription kit instructions, tissue total RNA was
reverse transcribed to cDNA, and related genes were detected by
real-time PCR. Survivin, p53 and Ki67 gene mRNA sequences
were queried from the NCBI database to design Real-time PCR
primers. All primers were synthesized by SBS Genetech Co.,
Ltd. Speciﬁc sequences are as follows (Tables 1–3). Gene
ampliﬁcation Ct value was determined by Real-time PCR, and
Ct values were negatively correlated to the initial DNA copy
number. GAPDH was treated as internal control using the rela-
tive quantiﬁcation method. For the homogenization process,
each sample was analyzed by the DCt value; DCt = target gene
Ct-reference gene Ct.
2.2.3. Plasmids construction and cell transfection
Survivin expression plasmid coding sequences obtained from
the survivin gene were inserted between the two restriction sites,
BamH I and Xho I, in the pcDNA3.1 plasmid (added EGFP tag
to detect the expression). Plasmid constructs were carried out by
the Beijing ComWin Biotech Co., Ltd.
An appropriate number of cells were inoculated through
culture plates, and 500 mL of complete medium was added into
each well, causing transfection cell density to reach 70%–80%.
Using 50 mL of serum-free medium, 1 mL of Lipofectamine
2000 was diluted. Then, the diluted plasmid and Lipofectamine
2000 were mixed, and incubated at room temperature for
20 min. After 4–6 h of culture, replace with fresh complete
medium, and continued to culture cells.
2.2.4. Cell proliferation detected by MTT
In accordance with the manufacturer's instructions of the
MTT Kit (Promega, G3582), a small amount of CellTiter 96®
Aqueous One Solution Reagent was directly added into culture
wells and incubated for 1–4 h, and absorbance was recorded on a
96-plate reader at 490 nm. At 490 nm, the measured absorbance
values and the number of living cells in cultures was directly
proportional.
2.2.5. Western-blotting
Cells were collected and lysed using 50 mL of RIPA lysis
buffer, simultaneously added with a protease inhibitor cocktail
(added 10 mL of cocktail to 1 mL RIPA by volume ratio), and
mixed by pipetting. After placed on ice for 30 min, cells were
sonicated, and ultrasound probes were used to deliver a short
shock on ice at an appropriate frequency, cleavage cocktail at
4 C, and centrifuged at 13000 r/min for 20 min. ThePrimer (50–30)
For: TGTCATAGAGCTGCAGGGTG
Rev: GTCGAGGAAGCTTTCAGGTG
For: TCAACAAGATGTTTTGCCAACTG
Rev: ATGTGCTGTGACTGCTTGTAGATG
For: CCACACTGTGTCGTCGTTTG
Rev: CCGTGCGCTTATCCATTCA
For: TGGAAGGACTCATGACCACA
Rev: TTCAGCTCAGGGATGACCTT
I67, antigen identiﬁed by monoclonal antibody Ki-67; GAPDH, glyc-
Table 2
Synthetic system of inverse transcription.
Components Volume per reaction
5× iScript reaction mix 4 mL
iScript reverse transciptase 1 mL
RNA template (1 mg RNA) 1 mg
Nuclease-free water Up to 20 mL
iScript reaction mix was purchased from Bio-Rad, Nuclease-free water
was purchased from Invitrogen.
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concentration was determined using a protein assay kit.
The gel was immersed in transfer buffer for 10 min in
equilibrium, the transfer ‘Sandwich’ assembled, transfer buffer
was added, and the electrode was plugged at 100 V for 45–
60 min. After the end of the membrane transfer, the PVDF
membrane was rinsed with TBS for 10–15 min, placed in TBS/T
blocking buffer containing 5% (w/v) skimmed milk, shaken at
room temperature for one hour, added with appropriate primary
antibody dilution [TBST dilution containing 1% (w/v) skim
milk], incubated for two hours at room temperature, and mem-
brane was rinsed three times with TBST every 5–10 min. Then,
the membrane was incubated in TBST diluted secondary anti-
body (1:10000, HRP labeled) containing 0.05% (w/v) nonfat
dry milk at room temperature for one hour, and rinsed three
times with TBST every 5–10 min. Exposed photographs of the
experimental results were saved. The experiment was repeated
three times. Quantity one v4.62 software was used to determine
the molecular strip gray scale value (strip track quantitative
method, Trace Tracking) according to different electrophoretic
bands; then, optical density values were plotted on the optical
density curve. Then, optical density was calculated according to
the area under the curve as quantitative electrophoretic bands,
and statistical analysis.
2.2.6. Bioinformatics analysis
Bioinformatics is an important method in studying protein
interactions and the protein signaling pathway. Line analysis
tool STRING 9.05 and the protein signaling pathway database,
and KEGG PATHWAY Database (http://www.genome.jp),
were used for protein interactions. As preliminarily analyzed,
survivin, p53 and Ki67 molecules are involved in the signaling
pathway and interacting proteins. The STRING database (http://
string-db.org) integrated experimental research data and
PubMed abstracts containing relevant results and bioinformatics
method forecast results, which are search systems for known or
predicted protein interactions.Table 3
Synthetic system of PCR.
Components Volume per reaction
SsoAdvanced SYBR Green
Super mix 5 mL
Forward primer (10 mM) 0.3 mL (300 nM)
Reverse primer (10 mM) 0.3 mL (300 nM)
cDNA template 100 ng
Nuclease-free water Up to 10 mL
SsoAdvanced SYBR Green Super mix was purchased from Bio-Rad.2.2.7. Cell invasion relevant experiments
Matrigel stored at −20 C was taken out for melting at 4 C
overnight. Matrigel was diluted with pre-cooled serum-free
DMEM medium to a ﬁnal concentration of 1 mg/mL, 100 mL of
diluted Matrigel was added on the bottom of the central chamber
of the Transwell, and incubated at 37 C through gel. For gum
reconstruction, 200 mL of DMEM culture medium was added
into each well. After cells were trypsinized, centrifuged to
remove the culture medium, washed cells with PBS, resus-
pended cells with serum-free medium, and cells were seeded on
the upper chamber of the Transwell. Culture medium containing
10% FBS was added into the lower chamber and cultured cells at
37 C. After the culture was completed, liquid in the upper
chamber was discarded, the upper chamber was removed, and a
cotton swab was used to wipe off those that did not pass through
the cell membrane. Fixed in 3.7% formaldehyde for 10 min,
crystal violet stained, and cells were observed under an inverted
microscope. Three horizons were randomly selected, and the
number of cells that passed through pores was calculated for
statistical analysis.
2.3. Statistical analysis
SPSS12.0 statistical software was used for analysis. Counted
data were analyzed by t-test, c2 test and correlation test using
Spearman correlation analysis. P < 0.05 means that the differ-
ence was statistically signiﬁcant.
3. Results
3.1. Survivin, p53 and Ki67 gene mRNA expression
levels in clinical tissue samples detected by real-time
PCR
As shown in Figure 1, in adjacent tissues, survivin, p53 and
Ki67 genes relative expression levels were 1.72 ± 0.9;
13.7 ± 5.7; 5.7 ± 1.3; while in cancer tissues, expression levels
of the three genes were signiﬁcantly upregulated, and the rela-
tive expression levels were: 53.7 ± 8.3; 66.7 ± 5.2; 61.0 ± 3.1
(P < 0.01).
3.2. Survivin overexpression and MTT detection of cell
apoptosis
Eukaryotic expression plasmids of survivin genes were
transfected by Hep-2 cells, EGFP expressions were detected
after 12 h, and signiﬁcant green ﬂuorescent protein expressions
can be observed in cells. As explained, survivin genes have been
normally expressed. Hep-2 cells that expressed for 24 h were
collected, survivin was detected by Western blot, and it could be
observed that the over-expression group was capable of
expressing by exogenous survivin; while for the no-load group,
endogenous expressions were only detected. Further, to detect
survivin gene on cell proliferation, relative survival rate of the
cells in survivin overexpression within 12–48 h was detected by
MTT. That was, absorbance (490 nm) of ﬁrst seed cells was used
as a standard to detect cell viability at relatively different time
periods. As explained, at a 12–48 h period, survivin gene
transfected cells; and relative survival rate was higher in the
control group, prompting survivin gene by regulating relevant
pathways, and suppressing normal apoptosis (Figure 2).
Figure 1. Survivin gene overexpression after 12 h of transfection is shown. Fluorescence microscopy detects ﬂuorescence signal (400×).
EGFP-survivin, exogenous expression; original survivin, intracellular endogenous expression.
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survivin gene overexpression detected by Western blot
The result showed over-expression of Survivin up-regulated
the level of p53 and Ki67. Quantity one v4.62 software
analyzed the gray value of the strip (Tracking Trace) based on
light density curves drawn by different electrophoretic bands of,
the light density, and then calculating the area under the optical
density curve was regard to the quantitative analysis of the
electrophoretic bands (Figure 3, Table 4).
3.4. Bioinformatics analysis of survivin, p53 and Ki67
interactions
By searching STRING database (http://string-db.org), survi-
vin, p53 and Ki67 interaction networks were obtained; and
MKI67 and TP53 were linked through cell cycle regulatory
signaling pathways. ‘Experimental evidence’ was selected as a
search condition, and received a large number of reported
literature on the relationship of MKI67 and TP53 [9–11]. TP53
and BIRC5 had interactions in cell apoptosis control, DNA
repair and other processes, which participated in the complex
cell cycle regulation [12] (Figure 4).Figure 2. MTT test results.
Relative survival rate standard initial cell absorbance value (490 nm
absorbance value).
Figure 3. p53 and Ki67 gene expression changes under survivin gene
overexpression.
Table 4
Signal of protein expressions measured by quantity one.
Groupa Gene
Survivin p53 Ki67
+ 52.9b ± 6.3** 18.2 ± 2.1* 16.2 ± 7.1
− 25.7 ± 3.7 11.7 ± 6.8 10.9 ± 0.9
*P < 0.05, **P < 0.01.
a + Transfected with survivin expression plasmid, − Transfected no load
control plasmid. b Quantity one Trace Tracking automatic calculation of
relative expression (that is, target protein band optical density signal, the
optical density signal using GAPDH for normalization process).
Figure 4. Bioinformatics analysis of survivin, p53 and Ki67 interactions.
TP53, tumor protein p53; BIRC5, baculoviral IAP repeat-containing 5;
MKI67,antigen identiﬁed by monoclonal antibody Ki-67; AURKB, aurora
kinase B; CDCA8, cell division cycle associated 8; MDM2, Mdm2 p53
binding protein homolog (mouse); CDKN1A, cyclin-dependentkinase in-
hibitor 1A (p21, Cip1); ATM, ataxia telangiectasia mutated; INCENP, inner
centromere protein antigens 135/155 kDa; SIRT1, sirtuin (silent mating
type information regulation 2 homolog) 1 (S. cerevisiae); BRCA1, breast
cancer 1, early onset; KAT2B, K(lysine) acetyltransferase 2B; RCHY1,
ring ﬁnger and CHY zinc ﬁnger domain containing 1.
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As shown in Figure 5, stained Hep-2 cells reached the lower
chamber (Figure 5A); while the number of cells that reached the
bottom of the chamber for Hep-2 cells transfected with emptyFigure 5. Cell invasion assay.
**: P < 0.01.vector (Figure 5B) and Hep-2 cells transfected with survivin
expression plasmid (Figure 5C).
3.6. Correlation analysis of Ki67, p53 and survivin
expression in laryngeal cancer
Using rank times the size of a linear variable for survivin,
Ki67, p53 expressions in laryngeal carcinoma, correlation
analysis showed that the three expression in laryngeal carcinoma
were positively correlated (r = 0.607, 0.541, 0.648; P < 0.01)
(Table 5).
4. Discussion
Cancer gene activation, tumor suppressor gene inactivation
as well as overexpression of anti-apoptotic genes are important
causes of cancer occurrence; and cancer gene expressions results
from the regulation of multiple complex factors. Multiple gene
cross-talking directly or indirectly leads to tumor occurrence.
Thus, tumor occurrence is usually not a single gene effect, but
rather results of the interaction of multiple genes, which presents
a challenge in tumor development studies.
Cancer gene activation and tumor suppressor gene inactiva-
tion under simultaneous action cause cells to lose their ability to
regulate their growth; that is, apoptosis regulation disorder,
thereby, cells does not undergo normal apoptosis. The signiﬁ-
cance of apoptosis lies in its ability to maintain cellular
Table 5
Correlation of Ki67, p53, survivin in laryngeal cancer.
Survivin p53
+ − r P + − r P
Ki67
+ 34 8 38 4
− 4 18 0.607 <0.01 6 16 0.648 <0.01
p53
+ 34 10
− 4 16 0.541 <0.01
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grammed cell death. Apoptosis is a physiologically active pro-
cess that involves a series of gene activation, expression,
regulation, as well as other roles. Normal apoptosis is a life-
sustaining body necessary for normal metabolism. Once
apoptosis-regulatory gene structure or regulatory regions mutate,
that is, cells does not undergo normal apoptosis, these cells
would ultimately develop into tumors.
Survivin is a member of the inhibitors of apoptosis protein
family. Survivin may inhibit apoptosis in two ways: direct in-
hibition of Caspase-3/7 (apoptosis terminal effector enzyme)
activity, and negative regulation of cell apoptosis induced by
various stimulation processes. Survivin with cyclin kinase
CDK4/2 can block the apoptosis signaling transduction
pathway. Survivin can act directly on Caspase by inhibiting
Caspasc-3/7 activity, and can also indirectly inhibit Caspase
through P21 interactions. Studies have shown that Survivin with
cell cycle regulation factors by CDK4 interactions lead to
CDK2/cyclin- E activation and ribosomal phosphorylation. Ri-
bosomal phosphorylation rapidly starts up cells to enter the cycle
and accelerates the conversion of the G1/S phase, causing P21
released from the Survivin-CDK4 complex combined with
mitochondrial pro-caspase-3 to inhibit caspase-3 activity, and
prevent mitochondrial release of cytochrome C; and thereby
inhibiting cell apoptosis [5]. Studies have also shown that
survivin can inhibit the Bax- and Fas-mediated apoptosis
pathway [13–15].
p53 is a tumor suppressor gene, and more than 50% of ma-
lignancies in clinic appear as mutated genes. The p53 gene, as
cell cycle regulators, can determine the degree of DNA mutation
in P53 cells. If DNA damage and mutations are small, it prompts
the cell to repair itself; and if DNA damage and mutations are
great, p53 induces apoptosis [16]. For this reason, p53 gene
mutations can cause cells not to undergo normal apoptosis,
and develop into cancer. It is also one of the causes of p53
mutation expressions in tumor cells.
Studies have shown that wild-type p53 can inhibit the
expression of survivin at the transcriptional level, and thereby
regulate normal cell cycle and apoptosis. This suggests that the
interaction of p53and survivin has an important role for the
normal start-up of cell apoptosis [17–19].
In our experiments, we found that the expression of p53 with
survivin in nasopharyngeal carcinoma was signiﬁcantly higher
than the adjacent controls, and at the same time, it was also
highly expressed in Hep-2 cells; and the expression of these two
proteins were highly associated. In survivin overexpression
conditions, p53 also appeared to increase. This prompts us that
p53 mutation is an important reason for apoptotic cells to lose
their normal control; and due to p53 mutations, they lost their
ability to inhibit survivin, and further hindered normal apoptosis,thereby causing cells to become cancerous. It also shows that
survivin can inhibit apoptosis and cause cell proliferation. Thus,
the dual role of inhibiting apoptosis and promoting cell prolif-
eration, in turn, promotes tumor development. To investigate the
further coordinating role of p53 and survivin in tumor devel-
opment, our future research would be transfection of p53
plasmid gene mutation expressions, as well as studies on the
expression and localization changes of survivin, and at the same
time, studies on p53 mutation sites (P53 common mutations:
aa129–146, 171–179, 234–260, 270–287) with survivin
interactions.
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